Position in OCGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$300,182
+$76,988 QoQ
Shares Held
196,198
+59.1% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 147 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. OCGN ranks #134 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | 17,163 | $2,278,044 | |||
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | TWST |
Twist Bioscience Corp
|
21,095 | $2,170,253 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 |
All Filings in OCGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,182 | 196,198 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $223,194 | 123,312 | Shares | Sole | 2026-04-27 | |
| 2024-09-30 | $154,917 | 156,167 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $227,295 | 146,642 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||